Gordon L. Archer
Clinical AdvisorDr. Gordon L. Archer, M.D. serves as Senior Associate Dean of Research at Virginia Commonwealth University (VCU) School of Medicine and has been its Director of the M.D./Ph.D. program since 2003. Dr. Archer served as an Advisor of Tetraphase Pharmaceuticals, Inc. He has been Professor of Medicine and Microbiology/Immunology at VCU since 1985 Dr. Archer has more than 30 years of academic medical experience. He began his career as an Instructor of Medicine in 1974 at the University of Michigan Medical School. He worked at VCU as an Assistant Professor of Medicine since 1975. From 1979 to 1985, he was an Associate Professor of Medicine at VCU, and from 1981 to 1985, he served as Associate Professor of Microbiology/Immunology. Dr. Archer also served as Chairman of the Division of Infectious Diseases of VCU from 1992 to 2005. His research interests include the genetic basis of bacterial resistance to antimicrobial agents with a focus on antibiotic resistance in staphylococci. Dr. Archer has been Head of Scientific Advisory Board of Cubist Pharmaceuticals Inc. since August 8, 2007 and serves as its Member of Scientific Advisory Board. He serves as Member of Scientific Advisory Board and Clinical Advisory Board of Micuron Pharmaceuticals. He has been Scientific Advisors at Spero Therapeutics, Inc. since May 2014. He served as Member of Scientific Advisory Board and Clinical Advisory Board of Achillion Pharmaceuticals, Inc. He served as Director of Cubist Pharmaceuticals Inc., from September 6, 2006 to August 8, 2007. He was a Member and Chair of the National Institutes of Health (NIH) Study Section on Bacteriology and Mycology and the NIH Study Section on Drug Discovery and Mechanisms of Resistance to Antimicrobials. Dr. Archer was a Member of the Food and Drug Administration's Antiinfective Advisory Board. He received his M.D. from the University of Virginia School of Medicine and completed residency training at the University of Michigan Medical Center, where he also served as Chief Resident and as a Fellow in Infectious Diseases. Dr. Archer received a Bachelor of Arts in Pre-med and German from Washington and Lee University in Virginia.
Positions
- Company NameSpero Therapeutics, Inc.Stock CodeSPROPositionClinical AdvisorColleagues
- EPEsther P. RajaveluCEO, President, CFO, Chief Business Officer, Treasurer & Director
- FEFrank Edward ThomasIndependent Chairman
- TKTimothy KeutzerChief Operating Officer
- JRJohn RaymondSenior Vice President of Finance & Business Operations
- DJDebra Jeske ZackChief Medical Officer
- ADAmy Dix RockChief Regulatory & Quality Officer
- CSCynthia SmithIndependent Director
- PGPaul G. AmbroseClinical Advisor
